Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Li Lu’s Himalaya Capital is famous for a bold, value-driven stance and a striking concentration in just a few bets. T...
Insider moves can reveal clues about a company's near-term prospects. This article dives into the remitly director's ...
Powell will continue to serve on the Federal Reserve Board after his chair term ends next month, steering a measured ...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
Huron's latest revenue milestone grabbed headlines, but a large fund still trimmed its position. This article breaks ...
A half-century-old rule for scaling software teams is breaking as AI fueled capital changes how firms grow. Investors...
XRP tests the $1.40 support as bulls fight for momentum. Here are the three signals shaping its path this week.
Investors are eyeing Atour's Q1 2026 updates. This guide explains how to read the atour (atat) 2026 earnings narrativ...
Nebius stock has drawn attention for rapid AI cloud growth, but two core risks could derail momentum. This guide give...
As the US Treasury aims to rebuild its cash balance toward 900B by June, Bitcoin traders face a potential liquidity s...
Bloom Energy stock plunged more than 10% on a single trading day, leaving investors wondering if the pullback marks a...